Related Experiment Video
Updated: Jun 2, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations
Julien Durand1, Antoine Lampron, Tania L Mazzuco
1Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal-Hôtel-Dieu, 3850 Saint Urbain Street, Montréal, Québec, Canada.
Background:
Mutations of β-catenin gene (CTNNB1) are frequent in adrenocortical adenomas (AA) and adrenocortical carcinomas (ACC). However, the target genes of β-catenin have not yet been identified in adrenocortical tumors.
Objective:
Our objective was to identify genes deregulated in adrenocortical tumors harboring CTNNB1 genetic alterations and nuclear accumulation of β-catenin.
Methods:
Microarray analysis identified a dataset of genes that were differently expressed between AA with CTNNB1 mutations and wild-type (WT) tumors. Within this dataset, the expression profiles of five genes were validated by real time-PCR (RT-PCR) in a cohort of 34 adrenocortical tissues (six AA and one ACC with CTNNB1 mutations, 13 AA and four ACC with WT CTNNB1, and 10 normal adrenal glands) and two human ACC cell lines. We then studied the effects of suppressing β-catenin transcriptional activity with the T-cell factor/β-catenin inhibitors PKF115-584 and PNU74654 on gene expression in H295R and SW13 cells.
Results:
RT-PCR analysis confirmed the overexpression of ISM1, RALBP1, and PDE2A and the down-regulation of PHYHIP in five of six AA harboring CTNNB1 mutations compared with WT AA (n = 13) and normal adrenal glands (n = 10). RALBP1 and PDE2A overexpression was also confirmed at the protein level by Western blotting analysis in mutated tumors. ENC1 was specifically overexpressed in three of three AA harboring CTNNB1 point mutations. mRNA expression and protein levels of RALBP1, PDE2A, and ENC1 were decreased in a dose-dependent manner in H295R cells after treatment with PKF115-584 or PNU74654.
Conclusion:
This study identified candidate genes deregulated in CTNNB1-mutated adrenocortical tumors that may lead to a better understanding of the role of the Wnt-β-catenin pathway in adrenocortical tumorigenesis.
Insights
Mutations in the β-catenin gene (CTNNB1) are common in adrenal tumors. This study identified key genes like RALBP1 and PDE2A that are deregulated in these tumors, offering insights into cancer development.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Mutations in the β-catenin gene (CTNNB1) are frequently observed in both adrenocortical adenomas (AA) and adrenocortical carcinomas (ACC).
- The specific target genes regulated by β-catenin in adrenocortical tumors remain largely unidentified.
Purpose of the Study:
- To identify genes that exhibit altered expression in adrenocortical tumors with CTNNB1 mutations.
- To investigate the impact of nuclear accumulation of β-catenin on gene expression profiles in these tumors.
Main Methods:
- Microarray analysis was employed to identify differentially expressed genes between CTNNB1-mutated and wild-type (WT) adrenocortical adenomas.
- Real-time PCR (RT-PCR) and Western blotting were used to validate gene and protein expression levels in a cohort of adrenal tissues and cell lines.
- The functional impact of inhibiting Wnt-β-catenin signaling on gene expression was assessed using specific inhibitors.
Main Results:
- Overexpression of ISM1, RALBP1, and PDE2A, and down-regulation of PHYHIP were confirmed in CTNNB1-mutated tumors compared to WT tumors and normal adrenal glands.
- RALBP1 and PDE2A overexpression was further validated at the protein level.
- ENC1 was found to be specifically overexpressed in tumors with CTNNB1 point mutations, and its expression decreased upon Wnt-β-catenin pathway inhibition.
Conclusions:
- This research successfully identified candidate genes, including RALBP1, PDE2A, and ENC1, that are deregulated in CTNNB1-mutated adrenocortical tumors.
- The findings contribute to a better understanding of the Wnt-β-catenin pathway's role in the development of adrenocortical tumors.
- These identified genes represent potential targets for future research and therapeutic strategies.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Canonical Wnt Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cell Specific Gene Expression
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...